The Lennox Gastaut Syndrome Market growth is gaining traction as pharmaceutical companies focus on developing effective therapies for this complex epileptic disorder. LGS is characterized by drug-resistant seizures, cognitive impairment, and behavioral issues, making management challenging. Growing adoption of novel anti-epileptic drugs (AEDs) and supportive therapies is driving market...
Portuguese (Brazil) 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Tiếng Việt